An innovative suite of clinical trials, matching therapies with individuals on the basis of genetic information, could one day hold the key to rare and uncommon cancers and give hope to patients who have exhausted other treatment options.

Launched today, the Genomic Cancer Medicine Program is a nationally-available program with two main areas of focus – clinical trials matching patients to therapies, and a risk-management program for families with an inherited high risk of cancer.

The Program was officially opened by NSW Minister for Health and Minister for Medical Research Brad Hazzard. The NSW Government invested $7 million over four years into the Genomic Cancer Medicine Program as part of a bigger $24 million investment through the Sydney Genomics Collaborative.